Sign In
Buy UNCY
$5.01
-0.290 (-5.47%)
At Close: Jul 31, 2026
Unicycive Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
06:00am, Tuesday, 07'th Sep 2021
LOS ALTOS, Calif., Sept. 7, 2021 /PRNewswire/ -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical stage biotechnology company developing therapies for patients with kidney disease, today annou
Unicycive Therapeutics Announces Second Quarter 2021 Financial Results
06:00am, Monday, 16'th Aug 2021
LOS ALTOS, Calif., Aug. 16, 2021 /PRNewswire/ -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical stage biotechnology company developing therapies for patients with kidney disease, today report
